Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Anastrozole
Drug ID BADD_D00142
Description Anastrozole is a non-steroidal aromatase inhibitor (AI), similar to [letrozole], used to decrease circulating estrogen levels in the treatment of postmenopausal women with estrogen-responsive breast cancer.[L8863] Anastrozole is also related to [exemestane], a steroidal AI, but its non-steroidal nature provides stark advantages including a lack of steroid-associated adverse effects such as weight gain and acne.[A186865] Aromatase inhibitors, including anastrozole, have become endocrine drugs of choice in the treatment of postmenopausal breast cancer due to a more favourable efficacy and adverse effect profile as compared to earlier estrogen receptor modulators such as [tamoxifen].[A186877,A186955] Anastrozole was first approved for use in the United States in 1995.[L8863]
Indications and Usage For adjuvant treatment of hormone receptor positive breast cancer , as well as hormonal treatment of advanced breast cancer in post-menopausal women. Has also been used to treat pubertal gynecomastia and McCune-Albright syndrome; however, manufacturer states that efficacy for these indications have not been established.
Marketing Status Prescription; Discontinued
ATC Code L02BG03
DrugBank ID DB01217
KEGG ID D00960
MeSH ID D000077384
PubChem ID 2187
TTD Drug ID D0W0BF
NDC Product Code 63850-6527; 0395-8157; 68554-0026; 0310-0201; 71335-1879; 65129-1119; 16729-035; 68071-1682; 71052-248; 72789-008; 65096-0117; 51991-620; 59651-236; 65072-0702; 63629-5269; 16571-421; 63850-0010; 82393-201; 62135-490; 63187-080; 62559-670; 50090-2453; 58623-0041; 55111-814; 68382-209; 51927-4435; 68001-155; 50090-5002; 65841-743; 76420-004; 50268-075; 0093-7536; 61200-104; 42291-085; 46014-1160; 70518-2484; 73377-120; 69988-0013; 50090-5812; 62756-428; 62157-077; 70934-488; 70518-2420; 60429-286; 68071-5203; 60687-112; 51552-1568; 46014-1009; 38779-2555; 0904-6195; 43063-383; 60440-2921; 53104-7627; 62175-710
Synonyms Anastrozole | 2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile) | Anastrazole | Arimidex | ICI D1033 | ZD-1033 | ZD 1033 | Zeneca ZD 1033 | ZD1033
Chemical Information
Molecular Formula C17H19N5
CAS Registry Number 120511-73-1
SMILES CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Cardiovascular disorderAdenylate kinase isoenzyme 1P00568Not Available9456245; 10473018; 14623544; 10514021; 10388095; 9556789; 15814851; 14513432; 11850229; 14687601; 15083379
OsteoporosisAdenylate kinase isoenzyme 1P00568Not Available9456245; 10473018; 14623544; 10514021; 10388095; 9556789; 15814851; 14513432; 11850229; 14687601; 15083379
Urogenital disorderAdenylate kinase isoenzyme 1P00568Not Available9456245; 10473018; 14623544; 10514021; 10388095; 9556789; 15814851; 14513432; 11850229; 14687601; 15083379
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Oedema14.05.06.010; 08.01.07.006--Not Available
Oedema peripheral14.05.06.011; 08.01.07.007; 02.05.04.007--
Oesophagitis07.08.05.0010.000754%
Oestradiol increased13.10.05.0140.000754%Not Available
Osteoarthritis15.01.04.0010.000754%Not Available
Osteolysis15.02.03.008; 14.04.04.0060.001131%Not Available
Osteonecrosis24.04.05.004; 15.02.04.0070.003017%
Osteoporosis15.02.03.002; 14.04.04.0020.003394%
Osteoporotic fracture14.04.04.007; 12.04.02.005; 15.08.02.007--Not Available
Ovarian cyst21.11.01.002; 16.04.03.0010.001508%Not Available
Pain08.01.08.0040.010182%
Pain in extremity15.03.04.0100.004525%
Pain in jaw15.02.01.0030.003394%Not Available
Palpitations02.01.02.0030.003017%
Pancreatitis07.18.01.0010.001508%
Pancytopenia01.03.03.0030.002640%Not Available
Panic attack19.06.04.0010.001508%Not Available
Papule23.03.03.0380.000754%Not Available
Paraesthesia17.02.06.0050.004148%
Paranoia19.05.01.0050.003017%Not Available
Parosmia22.04.03.007; 17.04.04.0020.000754%Not Available
Pathological fracture16.32.03.007; 15.08.02.008; 12.04.02.006--Not Available
Pelvic pain20.02.03.007; 07.01.06.012; 21.10.01.0010.000754%
Pharyngitis22.07.03.004; 11.01.13.003; 07.05.07.004--
Photosensitivity reaction23.03.09.0030.000754%
Platelet count decreased13.01.04.001--
Pneumonia22.07.01.003; 11.01.09.003--Not Available
Pneumonitis22.01.01.0060.001508%
Pollakiuria20.02.02.0070.000754%
Polycythaemia01.07.01.0010.001508%Not Available
The 9th Page    First    Pre   9 10 11 12 13    Next   Last    Total 16 Pages